Kuber Hospital

Details

Name :

Kuber Hospital

Address  :

12, Chanderlok Enclave
Pitam pura

Town  :

Delhi

State  :

Delhi

Country  :

INDIA

Post Code:

110034

Phone  :

91-11-27353246, 27352931, 27354408

Fax  :

91 11 42458192

Web URL  :

Kuber Hospital
Specialization
  • Dentistry
  • General Surgeon
  • Gynaecology
  • Internal Medicine
  • Obestetrician/Gynecologist
  • Orthodontist
  • Paediatrics
  • X-Ray
Facilities

Total Number Of Beds : 20

Speciality Type :

Other Facilities

  • X-Ray
  • Ultrasonography

Description

About Hospital
This Hospital was started in 1992 Since then the Hospital is striving to provide quality care of the people of Delhi at an affordable cost We at the Kuber hospital work with a philosophy of ethics dedication humanity and uncompromising high standards care Here we try to provide an homely amp aesthetic environment with sense of attachment and belonging to the patient The response of people has been very encouraging which is enthusiasm in us to carry on services with same vigour amp dedication

A LANDMARK OF PATIENT SATISFACTION
The need for an integrated basic health care facility in north west Delhi was being felt very acutely specially because of rapidly growing population in this part capital city Kuber hospital was stared to fulfill this need so that people can get quality comprehensive health care near to their homes with cost within their reach It is situated on main road No 44 at chanderlok enclave in Pitampura very easy to approach with a 20 bed capacity the hospital has a provision for different economic segments of society including a number of beds at subsidized charges


History

Kuber Hospital established in 1992
Polio to stay in india with collateral damage WHO

NEW DELHI The World Health Organisation WHO recently took India off the list of polioendemic countries but the campaign to stop the debilitating disease from recurrence will have to continue in some format or the other Eradication of polio is impossible because scientists had synthesised poliovirus in a test tube in 2002 The sequence of its geno... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More